Product Development (QbD & CMO)
Quality-by-Design product and process development, including development with and oversight of contract manufacturing organizations.
Overview
A product designed with quality built in is faster to register and more robust to manufacture; one developed without that rigor accumulates problems that surface at scale-up, submission or launch. PharmExpert supports formulation and process development under Quality by Design (ICH Q8/Q11), defining the target product profile, critical quality attributes and design space, whether developed in-house or with a contract manufacturing organization.
We begin with a developability assessment that establishes whether the concept is genuinely viable — manufacturable, stable and capable of meeting the target profile — and surfaces technical risks early, when they are cheapest to resolve. From there we guide formulation and process development grounded in real process understanding.
Design-of-experiments and a defined control strategy are central to our approach. Rather than a single trial-and-error path, we explore the design space systematically, so the resulting process is robust, well understood and defensible to regulators expecting QbD rigor.
Where development sits with a CMO, we provide the technical oversight that keeps it on track, scientifically sound and registrable — and we capture the development data and control strategy in dossier-ready form for Module 3. The result is a product that is not just developed, but developed to register and manufacture reliably.
What we do
- Target product profile and developability assessment
- QbD formulation and process development (CQAs, CPPs, design space)
- Design-of-experiments (DoE) and control-strategy definition
- CMO selection input and development oversight
- Development documentation for the dossier (Module 3)
- Scale-up readiness and risk assessment
Our process
- 1
Define
Establish the TPP, CQAs and development plan.
- 2
Develop
Run QbD formulation/process development and DoE.
- 3
Oversee
Manage in-house or CMO development to plan.
- 4
Document
Capture the control strategy and dossier-ready data.
What you receive
- Developability assessment and development plan
- QbD / DoE study reports and design space
- Control strategy
- Development documentation for Module 3
Who needs this
Companies developing new products or line extensions, teams developing with a CMO, and organizations needing QbD rigor for registration.
Frequently asked questions
Ready to improve your compliance?
Talk to an independent PharmExpert specialist about your GxP, regulatory or quality challenge. We respond within one business day.
